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ABSTRACT
OBJECTIVES
To investigate the role of body mass index (BMI), 
systolic blood pressure, and smoking behaviour 
in explaining the effect of education on the risk of 
cardiovascular disease outcomes.
DESIGN
Mendelian randomisation study.
SETTING
UK Biobank and international genome-wide 
association study data.
PARTICIPANTS
Predominantly participants of European ancestry.
EXPOSURE
Educational attainment, BMI, systolic blood pressure, 
and smoking behaviour in observational analysis, 
and randomly allocated genetic variants to instrument 
these traits in mendelian randomisation.
MAIN OUTCOMES MEASURE
The risk of coronary heart disease, stroke, myocardial 
infarction, and cardiovascular disease (all subtypes; 
all measured in odds ratio), and the degree to which 
this is mediated through BMI, systolic blood pressure, 
and smoking behaviour respectively.
RESULTS
Each additional standard deviation of education 
(3.6 years) was associated with a 13% lower risk 
of coronary heart disease (odds ratio 0.86, 95% 
confidence interval 0.84 to 0.89) in observational 
analysis and a 37% lower risk (0.63, 0.60 to 0.67) in 
mendelian randomisation analysis. As a proportion of 
the total risk reduction, BMI was estimated to mediate 
15% (95% confidence interval 13% to 17%) and 18% 
(14% to 23%) in the observational and mendelian 
randomisation estimates, respectively. Corresponding 
estimates were 11% (9% to 13%) and 21% (15% to 
27%) for systolic blood pressure and 19% (15% to 
22%) and 34% (17% to 50%) for smoking behaviour. 
All three risk factors combined were estimated to 
mediate 42% (36% to 48%) and 36% (5% to 68%) of 
the effect of education on coronary heart disease in 
observational and mendelian randomisation analyses, 
respectively. Similar results were obtained when 
investigating the risk of stroke, myocardial infarction, 
and cardiovascular disease.
CONCLUSIONS
BMI, systolic blood pressure, and smoking behaviour 
mediate a substantial proportion of the protective 
effect of education on the risk of cardiovascular 
outcomes and intervening on these would lead 
to reductions in cases of cardiovascular disease 
attributable to lower levels of education. However, 
more than half of the protective effect of education 
remains unexplained and requires further investigation.
Introduction
Cardiovascular disease is the leading cause of mortality 
worldwide, accounting for over 17 million deaths 
annually.1 Recent studies suggest that socioeconomic 
risk factors, such as education, play a causal role in 
the aetiology of cardiovascular disease.2-4 Tillmann 
and colleagues found that an additional 3.6 years of 
education reduced the risk of coronary heart disease 
by approximately one third.2 However, educational 
opportunities are not equitable throughout populations 
and education is inherently difficult to intervene on. 
Therefore, understanding the risk factors that might 
be driving the adverse later life outcomes associated 
with lower levels of education would provide the 
opportunity to reduce inequalities with interventions.
Existing studies suggest that body mass index 
(BMI), systolic blood pressure, and smoking behaviour 
partly explain differences in the risk of cardiovascular 
disease related to educational attainment.5-7 However, 
these studies have relied on observational mediation 
analyses that might suffer from biases. Traditional 
methods use one snapshot of a risk factor, which could 
incompletely capture a person’s lifetime exposure.8 For 
example, systolicblood pressure measured at one time 
point will suffer from measurement error due to day-to-
day fluctuations and will not capture changes across 
the life course. This measurement error can lead to an 
underestimation of mediation.8 Furthermore, other 
biases such as unmeasured confounding cannot be 
addressed by using observational methods.9
Mendelian randomisation uses genetic variants 
as instruments to estimate the effect of an exposure 
WHAT IS ALREADY KNOWN ON THIS TOPIC
Lower levels of education are causally related to a higher risk of cardiovascular 
disease
WHAT THIS STUDY ADDS
Body mass index, systolic blood pressure, and smoking behaviour mediate the 
effect of education
Cardiovascular disease attributable to lower levels of education can be reduced 
by intervening on these risk factors
For numbered affiliations see 
end of the article.
Correspondence to: A Carter 
alice.carter@bristol.ac.uk  
(or @alicerosecarter on Twitter 
ORCID 0000-0003-2817-4195)
Additional material is published 
online only. To view please visit 
the journal online.
Cite this as: BMJ 2019;365:l1855 
http://dx.doi.org/10.1136/bmj.l1855
Accepted: 25 March 2019
 o
n
 16 Septem
ber 2019 at Cam
bridge University Library. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.l1855 on 22 May 2019. Downloaded from 
RESEARCH
2 doi: 10.1136/bmj.l1855 | BMJ 2019;365:l1855 | the bmj
on an outcome of interest,10 exploiting the random 
allocation of genetic variants to infer causal effects that 
are robust to non-differential measurement error and 
confounding.10 Two-step mendelian randomisation for 
mediation analysis, unlike traditional observational 
mediation analysis approaches, is both sensitive to 
the causal effects of the mediator and corrects for its 
measurement error.11 Recent genome-wide association 
study meta-analyses have identified a number of 
genetic variants for educational attainment that could 
be used as instrumental variables.12 13
Mendelian randomisation has previously been 
used to show the causal effects of education on BMI, 
systolic blood pressure, and smoking behaviour 
and also the effects of BMI and smoking behaviour 
on cardiovascular disease.14-19 Although the results 
from these studies suggest that BMI, systolic blood 
pressure, and smoking behaviour are likely to explain 
some of the protective mechanisms of education on 
cardiovascular disease, they alone do not quantify the 
mediated effect. In this study, we investigated the role 
of BMI, systolic blood pressure, and lifetime smoking 
behaviour in mediating the causal effect of educational 
attainment on the risk of cardiovascular disease by 
using three complementary approaches: multivariable 
regression, one-sample mendelian randomisation, and 
two-sample mendelian randomisation. BMI, systolic 
blood pressure, and smoking behaviour were selected 
as intermediate risk factors based on the literature, 
implicating them as both being affected by education 
and as risk factors for cardiovascular disease, with 
availability of data across all three complementary 
methods. We consider the three risk factors both 
individually and simultaneously. Understanding the 
mechanisms by which education affects cardiovascular 
health could have powerful applications for public 
health policy. For this, it is important to understand 
the population-level implications of changes to BMI, 
systolic blood pressure, and smoking behaviour on 
inequalities in the risk of cardiovascular disease.
Methods
Overall study design
This study used multivariable regression of observa-
tional data, one-sample mendelian randomisation 
of individual level genetic data, and two-sample 
mendelian randomisation of summary level genetic 
data to investigate whether BMI, systolic blood 
pressure, and lifetime smoking behaviour explain the 
protective effect of education on the risk of coronary 
heart disease, stroke, myocardial infarction, and 
cardiovascular disease (all subtypes).
Data sources
UK Biobank
The UK Biobank recruited 503 317 British adults 
between 2006 and 2010. Participants attended 
assessment centres involving questionnaires, 
interviews, anthropometric, physical, and genetic 
measurements.20 21 In the observational analysis, 
we included 217 013 white British participants, with 
complete data on genotypes, age, sex, educational 
attainment, cardiovascular outcomes, BMI, systolic 
blood pressure, smoking behaviour, socioeconomic 
status (as measured by Townsend Deprivation Index 
at birth), and place of birth. Supplementary figure 1 
shows the exclusion criteria for the main UK Biobank 
analyses, and supplementary figure 2 shows the 
exclusion criteria for the genome-wide association 
studies carried out for systolic blood pressure and 
smoking. White British participants were defined 
by using both self-reported questionnaire data and 
similar genetic ancestry to the European ancestry 
principal components computed from the 1000 
genomes project.22
The supplementary methods show the data on 
educational attainment (as measure by highest achieved 
qualifications), BMI, systolic blood pressure, smoking 
behaviour, and all covariates. A continuous lifetime 
measure of smoking behaviour, incorporating smoking 
initiation, duration, heaviness, and cessation is used 
in this analysis. Full details are presented elsewhere.23 
Participants reported their highest qualification and age 
of leaving school if they did not have a degree. These were 
converted to the International Standard Classification 
for Education coding of educational attainment 
(supplementary table 1).13 We used available follow-up 
data where baseline data were missing. To account for 
the effects of antihypertensive treatment, participants 
who were taking antihypertensive drugs had 10 mm 
Hg added to their measured systolic blood pressure.24 
Supplementary table 2 shows that cardiovascular 
disease diagnoses (including diagnoses of coronary heart 
disease, stroke, and myocardial infarction) and events 
were ascertained through linkage mortality data and 
hospital episode statistics, with cases defined according 
to ICD-9 (international classification of diseases, ninth 
revision) and ICD-10 codes (international classification 
of diseases, 10th revision).25 We excluded participants 
who had experienced a cardiovascular disease event 
before the baseline assessment (prevalent cases) and 
we only considered first event, incident cases after the 
assessment centre.
Genome-wide association study meta-analyses
In the two-sample mendelian randomisation analysis, 
we obtained summary genetic associations from 
genome-wide association study data for each respective 
phenotype. For education, this was the Social Science 
Genetic Association Consortium genome-wide 
association study meta-analysis of years of schooling 
in 1 131 881 participants of European ancestry,13 with 
summary data made available for 766 345 of these 
participants. Instruments were selected as the 1271 
independent (pairwise r2 <0.1) genome-wide-wide 
significant single nucleotide polymorphisms after 
analysing data from the full sample.13 We obtained 
genetic estimates for BMI from the Genetic Investigation 
of Anthropometric Traits consortium’s 2018 genome-
wide association study meta-analysis of 681 275 
participants of European decent.26 Genetic association 
estimates for systolic blood pressure and smoking 
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behaviour were estimated from a genome-wide 
association study of 318 147 white British participants 
in the UK Biobank (see supplementary methods). 
Instruments for BMI, systolic blood pressure, and 
smoking behaviour were identified as the lead single 
nucleotide polymorphisms in loci reaching genome-
wide significance after clumping summary estimates 
from the largest available genome-wide association 
study for linkage disequilibrium threshold r2<0.001 
and distance >10 000 kb, by using a 1000 genomes 
European reference panel through the TwoSampleMR 
package (default settings of the ‘clump_data’ 
command) in the statistical software R.27 For coronary 
heart disease, we used publicly available genetic 
association estimates from the CARDIoGRAMplusC4D 
1000 Genomes-based genome-wide association 
study meta-analysis of 60 801 cases and 123 504 
controls.28 The definition for coronary heart disease 
was broad and inclusive, considering acute coronary 
syndrome, myocardial infarction, angina with one 
or angiographic stenoses of greater than 50%, and 
chronic stable angina. Details of the genome-wide 
association study for stroke and myocardial infarction, 
and further details for other genome-wide association 
study are provided in the supplementary methods. All 
genetic association estimates used in each two-sample 
mendelian randomisation analyses are provided in 
supplementary tables 4 to 18.
Statistical analysis
Effect of education on cardiovascular disease
In observational analysis of UK Biobank data, we 
used multivariable logistic regression to estimate the 
association of education with cardiovascular disease 
and its subtypes. We adjusted all analyses using UK 
Biobank data for potential confounders: age, sex, place 
of birth, birth distance from London, and Townsend 
Deprivation Index at birth. These confounders 
were determined a priori, with place of birth and 
birth distance from London included to control for 
population structure in the UK Biobank.3 29
In two-sample mendelian randomisation analysis, 
the effects of education on cardiovascular subtypes 
were investigated using ratio method mendelian 
randomisation with standard errors derived using 
the delta method.30 We used fixed-effect inverse-
variance weighted meta-analysis to pool mendelian 
randomisation estimates across individual single 
nucleotide polymorphisms.31
Mediation by BMI, systolic blood pressure, and 
smoking behaviour
In multivariable observational and one-sample 
mendelian randomisation analyses, when investi-
gating the degree to which the effects of education on 
cardiovascular disease and its subtypes are mediated 
through each risk factor (BMI, systolic blood pressure, 
and smoking behaviour) individually, we used the 
product of coefficients method to estimate the indirect 
effect (that is, the effect of education on cardiovascular 
disease that goes through the risk factor).32 This 
involved first estimating the effect of education on 
each risk factor individually, then multiplying this 
with the effect of that risk factor on the outcome after 
adjusting for education. We estimated the proportion 
of the overall effect of education on cardiovascular 
disease subtypes that was mediated by each risk 
factor by dividing the indirect effect by the total 
effect. Standard errors were derived by bootstrapping 
in the observational and one-sample mendelian 
randomisation analysis and by using the delta method 
in the two-sample mendelian randomisation analysis.
We used multivariable linear regression in the 
observational analysis to estimate the association 
of education with each risk factor after adjusting for 
confounders (as in the total effects models). We then 
estimated the effect of each risk factor on the individual 
cardiovascular disease subtypes with additional 
adjustment for self-reported educational attainment.33 
The two estimates were multiplied together to estimate 
the indirect effect (of education, through the risk factor).
We used the inverse-variance weighted mendelian 
randomisation approach for the two-sample 
mendelian randomisation to estimate the effect of 
education on each risk factor. We used regression-
based multivariable mendelian randomisation to 
estimate the effect of each risk factor on the risk of the 
considered cardiovascular disease subtypes, adjusting 
for genetic effect of the instruments on education.34 We 
estimated the indirect effect of education on the risk 
of each cardiovascular disease subtype through the 
considered risk factor by multiplying results from these 
two mendelian randomisation analyses.
Methods for investigating the role of all three risk 
factors together are presented in the supplementary 
methods.
One-sample mendelian randomisation and 
sensitivity analyses
One-sample mendelian randomisation analysis 
was carried out in the UK Biobank. Full details of 
the genetic variants used are in the supplementary 
methods and supplementary tables 19 to 21. In brief, 
a weighted allele score was created based on genome-
wide significant single nucleotide polymorphisms 
identified in recent genome-wide association study 
meta-analyses for the considered exposures (that is, 
educational attainment, BMI, systolic blood pressure, 
and smoking behaviour).12 23 35 These genome-wide 
association study estimates were selected from 
studies that did not include UK Biobank participants, 
so as to avoid participant overlap, and therefore, in 
some cases, the genome-wide association study and 
subsequent instruments differed from the genome-
wide association study studies used for the two-sample 
mendelian randomisation described previously. Table 
1 shows a summary of all phenotypes and genome-
wide association study data used. The variants in each 
instrument were harmonised for consistent directions of 
association and each single nucleotide polymorphism 
in the genetic score was weighted by its relative effect 
size in the respective genome-wide association study, 
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with effects combined in an additive model. Analyses 
using the UK Biobank were replicated using the risk 
difference scale. A range of sensitivity analyses were 
carried out, including exploring the assumption 
of no pleiotropy within mendelian randomisation 
analyses by using mendelian randomisation-Egger 
and weighted median mendelian randomisation.34 36 
One-sample mendelian randomisation analyses and 
multivariable observational associations between 
education and cardiovascular disease were repeated 
after stratifying for sex and age below or above the 
median (39-57 years compared with 58-72 years). On 
a subsample of participants with dietary recall data, 
an observational model was run considering diet 
and exercise as mediators in addition to BMI, systolic 
blood pressure, and smoking behaviour mediators. 
Full details of sensitivity analyses are provided in the 
supplementary methods.
Statistical software and ethical approval
We performed the analysis by using Stata version 14 
(StataCorp LP) and R version 3.4.3 (The R Foundation 
for Statistical Computing). We used the mrrobust 
package for Stata and the TwoSample MR package for 
R to facilitate MR analyses.27 37
Patient and public involvement
No patients or participants were involved in setting 
the research question or the outcome measures, nor 
were they involved in developing plans for design or 
implementation of the study. No patients were asked to 
advise on interpretation or writing up of results. There 
are no plans to disseminate the results of the research to 
study participants or the relevant patient community.
Results
UK Biobank cohort description
The UK Biobank sample used in the observational and 
one-sample mendelian randomisation analysis was 
comparable to the participants in UK Biobank as a 
whole, although the UK Biobank is not representative 
of the wider UK population (participants are typically 
more educated and of a higher socioeconomic status 
as compared with the general population).21 In the 
analysis sample, 38% of participants had over 19 
years of education, which is equivalent to a vocational 
qualification or degree and only 17% of participants 
left school with no formal qualifications after seven 
years (supplementary table 3). The standard deviation 
of educational attainment was 3.6 years, BMI was 4.69, 
and systolic blood pressure was 18.68 mm Hg. For 
lifetime smoking behaviour, one standard deviation 
increase is equivalent to, for example, an individual 
smoking 20 cigarettes a day for 15 years and stopping 
17 years ago, or an individual smoking 60 cigarettes a 
day for 13 years and stopping 22 years ago.23
Effect of education on the risk of coronary heart 
disease and stroke
Figure 1 shows that in observational analyses, one 
standard deviation of higher education was associated 
with a 14% lower risk of coronary heart disease with 
an odds ratio of 0.86 (95% confidence interval 0.84 to 
0.89). Two-sample mendelian randomisation analysis 
indicated a stronger protective effect with an odds ratio 
of 0.63 (0.60 to 0.67).
Figure 1 shows that similar protective associations 
were found for the effect of education on other 
cardiovascular disease outcomes. In observational 
analyses, a one standard deviation higher education 
was associated with an 11% lower risk of stroke, with 
an odds ratio of 0.89 (95% confidence interval 0.85 
to 0.93). In two-sample mendelian randomisation 
analyses the protective effect was stronger, with an 
odds ratio of 0.71 (0.68 to 0.75).
All three approaches also provided consistent 
evidence for a protective effect of education with 
risk of cardiovascular disease and its subtypes 
(supplementary figures 6 and 7).
Effect of education on BMI, systolic blood pressure, 
and smoking behaviour
Figure 2 and supplementary figures 8 to 11 show 
that in all methods, a longer time in education was 
associated with lower BMI, systolic blood pressure, 
and smoking behaviour.
Effect of BMI, systolic blood pressure, and smoking 
behaviour on the risk of cardiovascular disease 
outcomes
Figure 3 shows that both observational and two-sample 
mendelian randomisation analyses consistently 
Table 1 | Summary of phenotypes and genome-wide association study (GWAS) data used as instrumental variables across analyses
Exposure Multivariable observational analysis*
Mendelian randomisation
One-sample Two-sample
Educational attainment Self-reported highest qualification 
mapped to ISCED years of schooling
Weighted allele score, using genome-wide significance SNPs 
(n=74) and β weights from Okbay and colleagues, 2016 58
Individual SNPs from Lee and col-
leagues, 2018 13 (n=1271)
BMI Measured weight and height Weighted allele score, using genome-wide significance SNPs 
(n=77) and β weights from Locke and colleagues, 2015 35
Individual SNPs from Yengo and 
 colleagues, 2018 26 (n=360)
Systolic blood pressure Median of two  automated blood 
 pressure measurements
Weighted allele score, using genome-wide significance SNPs 
(n=65 and 55 sample 1 and 2 respectively)  from a split sample 
GWAS in the UK Biobank†
Individual SNPs from SBP GWAS carried 
out as part of this work on full UK 
Biobank sample† (n=191)
Smoking behaviour Estimate of lifetime smoking behaviour 
using self-report data 
Weighted allele score, using genome-wide significance SNPs 
(n=18 and 15 sample 1 and 2 respectively) from a split sample 
GWAS in UK Biobank†23
Individual SNPs from Wootton and 
 colleagues, 2018 using full  
UK Biobank sample 23 (n=126)
*All in the UK Biobank.
†Full methods in the supplementary material.
ISCED=International Standard Classification for Education; SNPs=single nucleotide polymorphisms; GWAS=genome-wide association study
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supported an increased risk of coronary heart disease 
with higher BMI, systolic blood pressure, and smoking 
behaviour, after adjusting for education. The effect of 
each risk factor was less consistent in the one-sample 
mendelian randomisation and estimates had wide 
confidence intervals (supplementary figure 12).
Mediation by BMI, systolic blood pressure, and 
smoking behaviour
Figure 4 shows that in the observational analysis, 
the proportion of the effect of education on the risk 
of coronary heart disease mediated by BMI was 15% 
(95% confidence interval 13% to 17%), 11% for 
systolic blood pressure (9% to 13%), and 19% for 
smoking behaviour (15% to 22%). In the two-sample 
mendelian randomisation analysis, the percentage 
mediated by BMI was 18% (14% to 23%), 21% for 
systolic blood pressure (15% to 26%), and 34% for 
smoking behaviour (95% confidence interval 17% to 
50%). In observational analyses, combining all three 
risk factors explained 42% (36% to 48%) of the effect 
of education on the risk of coronary heart disease. In 
two-sample mendelian randomisation, combining all 
three risk factors explained 36% (5% to 68%) of the 
effect of education on coronary heart disease.
Similar results were found for other cardiovascular 
disease subtypes in multivariable observational 
analyses. Smoking behaviour consistently mediated 
around 20% of the association. BMI explained between 
10% and 17% of the association between education 
and cardiovascular disease and its subtypes; systolic 
blood pressure explained between 8% and 18% of the 
association. In two-sample mendelian randomisation 
analyses, smoking behaviour explained up to 34% of 
the association between education and cardiovascular 
disease subtypes; BMI estimated up to 18% and 
systolic blood pressure up to 28% of the association. 
One-sample mendelian randomisation analyses 
estimated similar amounts of the association explained 
by systolic blood pressure and smoking behaviour but 
was less consistent for BMI (supplementary figure 13).
Sensitivity analyses
Table 2 and supplementary figures 14 to 17 show that 
results from sensitivity analyses were comparable, but 
produced less precise estimates with wider confidence 
intervals. Unadjusted and age and sex adjusted models 
were also consistent with the main fully adjusted models 
for multivariable analyses (supplementary tables 22 
and 23). Analyses stratified by age and separately 
by sex were consistent with the non-stratified main 
results, although confidence intervals were wide in 
the mendelian randomisation (supplementary figures 
14 and 15). The effects of each mediator individually, 
and combined, estimated on the risk difference scale 
and by using the difference method in individual data 
were consistent with the main analyses on the log 
odds ratio scale (supplementary figure 16). Including 
diet and exercise measures in addition to BMI, systolic 
blood pressure, and smoking behaviour did not 
change the amount of the association that education 
to cardiovascular disease (all subtypes) explained 
(supplementary figure 17).
Discussion
Our observational and genetic analyses support that 
the effect of education on the risk of cardiovascular 
disease is mediated by approximately up to one 
third through any of BMI, systolic blood pressure, or 
smoking behaviour. When investigating all three risk 
factors together, it was estimated that around 40% of 
the association between education and cardiovascular 
disease is explained by the three risk factors combined, 
both in observational and mendelian randomisation 
analyses. Note that over half of the effects of education 
remain unexplained in these analyses. Our main 
analysis did not consider the contributions of exercise, 
diet, health system factors, lipid profile, and glycaemic 
traits.38-44 However, these risk factors are likely to be 
inter-related with the risk factors already considered in 
our analysis. For example, much of the effect of diet 
and activity on cardiovascular disease is likely to act 
through BMI and systolic blood pressure, and therefore 
the cumulative effect of BMI, systolic blood pressure, 
and smoking behaviour together is likely to be 
capturing some of their effects. Indeed, in a sensitivity 
analysis including diet and exercise alongside BMI, 
systolic blood pressure, and smoking behaviour, they 
explain no more of the association between education 
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Fig 1 | The effect of a one standard deviation increase in education on the risk of 
cardiovascular disease outcomes
BMI
Systolic blood pressure
Smoking
-0.10 (-0.10 to -0.09)
-0.22 (-0.24 to -0.20)
-0.06 (-0.07 to -0.06)
-0.15 (-0.17 to -0.14)
-0.13 (-0.13 to -0.13)
-0.22 (-0.23 to -0.21)
-0.3 -0.1 0-0.2 0.1
Observational
Two-sample mendelian randomisation
Risk factor Mean difference
(95% CI)
Mean difference
(95% CI)
Fig 2 | Estimates for the association between one standard deviation higher education 
and intermediate risk factors
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and cardiovascular disease than the three mediators in 
our main analysis.
We have triangulated evidence across three distinct 
approaches. Although the point estimates vary, along 
with the mediation results, all three approaches 
indicate the same conclusions. Our mendelian 
randomisation estimates are much larger in magnitude 
than the observational results. In mendelian 
randomisation, the genetic instruments used to proxy 
the exposure and mediators estimate their lifetime 
effect, rather than one snapshot, which could explain 
the larger estimates in mendelian randomisation. 
Additionally, this could be owing to bias from negative 
confounding or measurement error in multivariable 
analyses. Cases recruited to the case-control studies 
included in two-sample analyses might represent 
a more extreme phenotype than in cohort studies 
such as the UK Biobank. The two-sample mendelian 
randomisation estimates are more precise than the 
one-sample mendelian randomisation results from the 
UK Biobank, likely related to the larger sample sizes 
and the number of cases.
Findings in context
Mendelian randomisation studies have previously 
investigated the causal effects of education on 
coronary heart disease, BMI, systolic blood pressure, 
and smoking behaviour,2 14-16 with others further 
estimating the effects of BMI and smoking behaviour 
on cardiovascular disease.18 19 Our current study makes 
several notable advances. We have used the most 
recent genome-wide association study of educational 
attainment to optimise the power of our two-sample 
mendelian randomisation analysis. With the larger 
sample size, the instruments selected from this study 
explained approximately 12% of the variance in 
education, as compared with the 3% accounted for 
in the previous iteration.12 13 Similarly, by leveraging 
the power of the UK Biobank and recent large-scale 
genome-wide association study meta-analyses, we 
were able to study additional cardiovascular outcomes, 
including stroke and myocardial infarction. In addition 
to the overall effects of the considered risk factors on 
cardiovascular disease, we were able to estimate the 
proportion of the effect of education that they mediate by 
using network (or two-step) mendelian randomisation, 
a recently developed method.11 32 Genetic instruments 
for smoking behaviour are limited and are typically 
related to binary measures that would introduce severe 
bias in mendelian randomisation.45 The development 
of a genome-wide association study for the continuous 
measure of lifetime smoking behaviour has allowed us 
to include this in a mediation model.23
Several studies have used observational multivariable 
regression methods to support mediating roles of 
BMI, systolic blood pressure, and smoking behaviour 
in the pathway between education and the risk of 
cardiovascular disease,5 6 46 47 with consistent results 
obtained by using various measures of education, 
including time spent in schooling and academic 
qualifications. In an analysis of Dutch participants, 
Kershaw and colleagues attributed almost 27% of the 
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Fig 3 | Associations of a one standard deviation higher risk factor on the risk of cardiovascular disease outcomes
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association between education and coronary heart 
disease to smoking behaviour, with 10% and 5% 
attributed to obesity and hypertension respectively.46 
Similarly, Dégano and colleagues found 7% and 14% of 
the association between education and cardiovascular 
disease could be explained by BMI and hypertension 
respectively.6 However, they did not find any evidence 
of smoking behaviour mediating the association. 
Veronesi and colleagues analysed their data stratified 
by sex, but consistently found mediating effects of 
systolic blood pressure and smoking behaviour in both 
men and women.47 The findings in our study show that 
observational estimates underestimate the mediating 
role of smoking behaviour, BMI, and systolic blood 
pressure compared with mendelian randomisation, 
likely due to measurement error in the mediators that 
bias observational estimates towards the null, but do 
not affect mendelian randomisation estimates to the 
same degree.11 Given the importance of measurement 
error as a source of bias in mediation analysis,8 the 
mendelian randomisation approach offers favourable 
opportunities for understanding mediation.
Strengths and limitations
The major strength of our work is that it allowed for 
assessment of the causal role of mediators by using 
mendelian randomisation, an approach that is 
robust to non-differential measurement error in the 
mediator. We have used multiple data sources and 
approaches, each with different potential sources of 
biases, to thus improve the reliability of our findings 
through triangulation.48 Furthermore, the mediated 
effects estimated were consistent across the two 
approaches and in the statistical sensitivity analyses. 
The imprecision in the one-sample mendelian 
randomisation analysis showed the need for very large 
sample sizes to achieve enough statistical power when 
estimating mediation in a mendelian randomisation 
framework. The results were complemented by the two-
sample mendelian randomisation approach, which 
had greater statistical power, but might be susceptible 
to alternative sources of bias, including those related 
to participant overlap in the samples used to obtain 
genetic association estimates for the exposures and 
outcomes.49 Existing genome-wide association study 
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Fig 4 | Estimates for the effect of education on cardiovascular disease outcomes explained by the risk factors. 
Combined estimates refer to the effect of BMI, systolic blood pressure, and smoking behaviour considered together in 
one model
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meta-analyses of systolic blood pressure have adjusted 
for BMI as a covariate, which could introduce collider 
bias,50 51 and for this reason we performed a genome-
wide association study of systolic blood pressure in the 
UK Biobank to select instruments, without adjusting 
for BMI. We also applied a ‘split sample’ systolic blood 
pressure genome-wide association study approach 
on unrelated individuals in the UK Biobank for use 
in individual-level data (one-sample) mendelian 
randomisation to avoid overlapping populations in 
the genetic association estimates for the exposure and 
outcome,52 and any associated bias.49 53 To this end, 
the one-sample mendelian randomisation entirely 
avoided any population overlap when obtaining 
genetic estimates for the exposures and the outcomes.
For all cardiovascular disease subtypes and 
individual risk factors considered, the largest 
effects of education were consistently seen with 
the mendelian randomisation approaches, with 
smaller effects seen in the analysis of observational 
data. Measurement error in a mediator leads to 
an underestimation of the proportion mediated, 
so the discrepancy between our observational 
and mendelian randomisation analyses could be 
attributable to mendelian randomisation analyses 
suffering less bias from measurement error.8 BMI is 
accurately measured and has little daily variation—
and correspondingly the estimates of the proportion 
of effect mediated by BMI in the observational and 
mendelian randomisation analyses are similar 
(15% and 18% respectively). In contrast, systolic 
blood pressure and lifetime smoking behaviour are 
difficult to measure accurately—and the estimated 
proportion mediated is smaller in the observational 
analysis than the mendelian randomisation (11% 
and 1% respectively for systolic blood pressure, and 
19% and 34% respectively for smoking behaviour). 
Measurement error could also be introduced by 
participants over-reporting traits perceived to be 
‘desirable’ such as education and underreporting 
traits perceived to be ‘undesirable’ such as smoking 
behaviour.54 The estimates for all three risk factors 
together were more similar between observational 
and mendelian randomisation estimates, although 
for all models, the confidence intervals were wide. 
Note that although mendelian randomisation is 
Table 2 | Mendelian randomisation (MR) sensitivity analyses
Analysis
Two-sample One-sample
Estimate (95% CI) P value Estimate (95% CI) P value
Education-coronary heart disease
IVW 0.63 (0.60 to 0.67) <0.001 0.51 (0.26 to 1.00) 0.05
MR-Egger 0.68 (0.54 to 0.85) 0.001 0.54 (0.12 to 2.34) 0.41
MR-Egger intercept NA 0.37 NA 0.93
Weighted median 0.62 (0.57 to 0.67) <0.001 0.98 (0.96 to 0.99) 0.33
Education-stroke
IVW 0.71 (0.68 to 0.75) <0.001 0.46 (0.30 to 0.71) <0.001
MR-Egger 0.72 (0.60 to 0.87) 0.001 0.57 (0.22 to 1.47) 0.25
MR-Egger intercept NA 0.76 NA 0.60
Weighted median 0.71 (0.66 to 0.76) <0.001 0.99 (0.98 to 1.00) 0.002
Education-myocardial infarction
IVW 0.61 (0.58 to 0.65) <0.001 0.18 (0.08 to 0.38) <0.001
MR-Egger 0.67 (0.52 to 0.85) 0.001 0.20 (0.04 to 1.03) 0.05
MR-Egger intercept NA 0.39 NA 0.88
Weighted median 0.59 (0.54 to 0.65) <0.001 0.99 (0.98 to 1.00) 0.002
Education-cardiovascular disease
IVW NA NA 0.64 (0.51 to 0.82) <0.001
MR-Egger NA NA 0.57 (0.34 to 0.95) 0.03
MR-Egger intercept NA NA NA 0.59
Weighted median NA NA 0.96 (0.94 to 0.98) <0.001
Education-BMI
IVW −0.22 (−0.24 to −0.20) <0.001 −0.36 (−0.49 to −0.23) <0.001
MR-Egger −0.28 (−0.49 to −0.07) 0.009 −0.15 (−0.41 to 0.12) 0.29
MR-Egger intercept NA 0.99 NA 0.08
Weighted median −0.27 (−0.30 to −0.23) <0.001 −0.51 (−0.62 to −0.39) <0.001
Education-systolic blood pressure
IVW −0.15 (−0.17 to −0.14) <0.001 −0.14 (−0.24 to −0.04) 0.005
MR-Egger −0.13 (−0.21 to −0.05) 0.002 −0.10 (−0.30 to 0.11) 0.37
MR-Egger intercept NA 0.32 NA 0.65
Weighted median −0.18 (−0.21 to −0.16) <0.001 −0.12 (−0.21 to −0.03) 0.008
Education-smoking
IVW −0.32 (−0.33 to −0.31) <0.001 −0.37 (−0.47 to −0.28) <0.001
MR-Egger −0.29 (−0.36 to −0.22) <0.001 −0.40 (−0.60 to −0.20) <0.001
MR-Egger intercept NA NA NA 0.73
Weighted median −0.35 (−0.37 to −0.33) <0.001 −0.37 (−0.46 to −0.29) <0.001
IVW=inverse-variance weighted; NA=not applicable
Coronary heart disease, stroke, and myocardial infarction are in odds ratio units. BMI, systolic blood pressure, and smoking behaviour are in standard 
deviation units. In one-sample analyses, the weighted median was estimated on the risk difference scale and converted to odds ratio by using linear 
combinations.
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more robust to measurement error, the instruments 
might not necessarily be capturing all aspects of 
the exposure phenotype under consideration. For 
example, the instruments for systolic blood pressure 
capture average systolic blood pressure but might not 
necessarily reflect the variability in blood pressure.
Estimates from mendelian randomisation analyses 
are robust to reverse causation bias, owing to the 
random allocation of genetic instruments at conception 
(and thus before development of the outcome under 
consideration). Although Tyrrell and colleagues have 
previously used mendelian randomisation to suggest 
an effect of BMI on education,55 and the relationship 
between education and BMI might be bi-directional, 
in our analyses where we focused on one direction of 
effect (that from education to BMI) the use of a large 
number of strong instruments for education makes 
it unlikely that the effect estimates derived from 
mendelian randomisation are biased due to reverse 
causation.
Another limitation of the mendelian randomisation 
approach is that estimates can be biased by pleiotropic 
pathways where the instrument is associated with the 
outcome through a phenotype independent of the 
exposure under consideration. To investigate this 
possibility, we additionally performed mendelian 
randomisation-Egger and weighted median sensitivity 
analyses that are more robust to such pleiotropy,34 36 56 
which produced results consistent with those from 
the main mendelian randomisation analyses. If we 
assume that the genetic variants have a monotonic 
effect on the exposure, mendelian randomisation 
estimates will reflect the average effect of the 
exposure on the outcome for all individuals whose 
exposure was affected by the genetic instrument. We 
found little evidence of heterogeneity in the effect of 
the exposures. This suggests that the effects of the 
single nucleotide polymorphisms on the exposure 
might be similar across the population, in which case 
the mendelian randomisation estimate could be a 
relatively unbiased estimate of the average effect in 
the population.
Analyses in the UK Biobank were carried out on 
white, British participants, potentially limiting the 
generalisability of our results to other populations 
and ethnicities. However, two-sample mendelian 
randomisation analyses were not exclusive to white 
European participants (although proportions were 
low for other populations) and produced consistent 
results to one-sample mendelian randomisation 
analyses. The UK Biobank is not representative of the 
UK population as a whole and is subject to healthy 
volunteer bias.56 57
When estimating the indirect effects of a mediator 
on a binary outcome, the product of the coefficients 
method results in the least amount of bias,33 and as 
such we used this approach for estimating the effects 
of education through each risk factor individually. 
However, this method cannot currently be used to 
consider multiple mediators simultaneously in a 
mendelian randomisation model. For this reason, 
we used the difference method for estimating the 
effect of education through the three risk factors 
collectively with mendelian randomisation. 
Although such an approach could introduce a 
theoretical risk of bias when investigating a binary 
outcome, individual level data analyses in the 
UK Biobank were also carried out on a linear risk 
difference scale to minimise any related issues. 
Estimates for the effect of education through the 
risk factors collectively were consistent between 
different scales in these analyses, and as such we 
would not expect any potential biases to alter the 
interpretation of our results.
Clinical and public health implications
Past policies that increase the duration of compulsory 
education have improved health and such endeavours 
must continue.4 However, intervening directly on 
education is difficult to achieve without social and 
political reforms. The findings of this study have 
notable implications for policymakers as they 
identify potential strategies for reducing education 
inequalities in health. Furthermore, they also 
produce quantitative estimates of this, allowing 
specific consideration of the potential impact to 
public health. That BMI, systolic blood pressure, and 
smoking behaviour together explain less than half of 
the overall effect of education is an important finding 
of this work. Further research identifying the other 
related factors and the interplay between them will be 
key to reducing social inequalities in cardiovascular 
disease. Furthermore, work investigating more 
diverse populations will be necessary to support 
the extrapolation of these findings outside of the 
considered contexts.
Conclusion
By using distinct analytical methods, including genetic 
approaches that can draw causal inference, our results 
suggest that interventions aimed at reducing BMI, 
systolic blood pressure, and smoking behaviour in 
European populations would lead to reductions in 
cases of cardiovascular disease attributable to lower 
levels of education. Importantly, over half of the effect 
of education on the risk of cardiovascular disease is 
not mediated through these risk factors and further 
work is required towards investigating this.
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